By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Thursday, September 23rd. Please refresh for updates.
Pfizer (NYSE:PFE) stock rose 0.8% after the Food and Drug Administration approved the drugmaker’s booster shots of its Covid-19 vaccine for older people and other vulnerable Americans.
Darden Restaurants (NYSE:DRI) stock rose 4.2% after the owner of Olive Garden and Longhorn Steakhouse reported strong first-quarter results and raised its 2022 outlook, as well declaring a quarterly dividend and an additional $750 million stock buyback.
Rite Aid (NYSE:RAD) stock fell 3.8% after the chain of pharmacies reported a hefty second quarter net loss from continuing operations of over $100 million, even as the company raised its full-year earnings guidance.
Salesforce (NYSE:CRM) stock rose 2.3% following the software company lifting its full-year revenue outlook and offering up upbeat 2023 guidance.
Facebook (NASDAQ:FB) stock rose 0.7%, rebounding after Wednesday’s 4% loss, following comments from marketing head Graham (NYSE:GHM) Mudd that the social media giant is under-reporting the results of its business on Apple (NASDAQ:AAPL) devices. This lessened worries associated with changes to the iPhone maker's privacy rules.
Blackberry (TSX:BB) stock rose 8% after the handheld device maker, and occasional meme favorite, reported better-than-expected second-quarter results, helped by demand for Internet of Things solutions.
Biogen (NASDAQ:BIIB) stock rose 0.8% on the back of investment firm Needham sticking with its ‘buy’ rating for the biotech company, saying the stock market has not priced in the potential upside for new drugs.
HB Fuller (NYSE:FUL) stock rose 2.7% after the chemicals company reported better-than-expected organic revenue growth, climbing by double digits.
Roku (NASDAQ:ROKU) stock rose 2.8%, helped by Guggenheim upgrading its investment stance to ‘buy’ from ‘neutral’, citing the streaming hardware company's inroads into the international market.